DYNE THERAPEUTICS INC (DYN) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:DYN • US26818M1080

16.8 USD
+0.25 (+1.51%)
At close: Feb 6, 2026
16.9202 USD
+0.12 (+0.72%)
After Hours: 2/6/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
DYN revenue by date.DYN revenue by date.
N/AN/AN/AN/A
405.87%		N/A
165.57%		N/A
78.48%		N/A
26.23%		N/A
21.89%		N/A
12.78%
EBITDA
YoY % growth
DYN ebitda by date.DYN ebitda by date.
-4.78M-13.56M
-183.68%		-57.95M
-327.36%		-148.94M
-157.01%		-169.28M
-13.66%		-240.489M
-42.07%		-342.213M
-42.30%		N/A
-31.40%		N/A
-17.76%		N/A
-8.13%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
DYN ebit by date.DYN ebit by date.
-4.8M-13.83M
-188.13%		-58.65M
-324.08%		-150.03M
-155.81%		-170.96M
-13.95%		-242.162M
-41.65%		-343.886M
-42.01%		N/A
-36.52%		N/A
-9.15%		N/A
0.94%		N/A
31.14%		N/A
116.94%		N/A
964.66%		N/A
34.34%		N/A
32.21%		N/A
15.36%
Operating Margin
DYN operating margin by date.DYN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DYN eps by date.DYN eps by date.
N/AN/AN/A-2.91
-15.59%		-3.24
-11.34%		-3.94
-21.60%		-3.35
14.97%		N/A
-6.45%		N/A
6.87%		N/A
8.40%		N/A
34.00%		N/A
126.16%		N/A
459.62%		N/A
63.00%		N/A
33.94%		N/A
14.90%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.78
11.38%		-0.82
21.48%		-0.84
13.32%		-0.86
-12.79%		-0.86
-10.41%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-120.19M
-25.94%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-119.08M
-22.63%		-125.273M
-2.37%		-127.85M
-10.41%		-133.078M
-16.85%		-135.54M
-13.82%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.76
20.83%		-0.850.0910.13%
Q2 2025
Q2Q % growth		 -0.97
-38.57%		-0.96-0.01-0.60%
Q1 2025
Q2Q % growth		 -1.05
-29.63%		-0.89-0.16-18.24%
Q4 2024
Q2Q % growth		 -0.88
19.27%		-0.970.099.33%
Q3 2024
Q2Q % growth		 -0.96
3.03%		-0.72-0.24-33.50%
Q2 2024
Q2Q % growth		 -0.70
35.19%		-0.730.033.47%
Q1 2024
Q2Q % growth		 -0.81
-3.85%		-0.810.00-0.25%
Q4 2023
Q2Q % growth		 -1.09
-47.30%		-0.93-0.16-17.73%
Q3 2023
Q2Q % growth		 -0.99
-23.75%		-0.84-0.15-17.74%
Q2 2023
Q2Q % growth		 -1.08
-6.93%		-0.82-0.26-32.42%
Q1 2023
Q2Q % growth		 -0.78
-13.04%		-0.780.00-0.46%
Q4 2022
Q2Q % growth		 -0.74
26.00%		-0.850.1113.29%
Q3 2022
Q2Q % growth		 -0.80
3.61%		-0.930.1314.06%
Q2 2022
Q2Q % growth		 -1.01
-74.14%		-0.78-0.23-29.03%
Q1 2022
Q2Q % growth		 -0.69
-38.00%		-0.890.2022.59%
Q4 2021
Q2Q % growth		 -1.00
-56.25%		-1.000.00-0.01%
Q3 2021
Q2Q % growth		 -0.83
58.71%		-0.65-0.18-27.41%
Q2 2021
Q2Q % growth		 -0.58 -0.55-0.03-5.37%
Q1 2021
Q2Q % growth		 -0.50 -0.610.1117.77%
Q4 2020
Q2Q % growth		 -0.64 -0.38-0.26-70.34%
Q3 2020
Q2Q % growth		 -2.01 -0.88-1.13-127.44%
DYN Yearly EPS VS EstimatesDYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
DYN Yearly Revenue VS EstimatesDYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -7.04% 0.71% 3.6%
RevenueN/A N/A N/A N/A